- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease ; volume:8 ; number:1 ; day:13 ; month:9 ; year:2013 ; pages:1 ; date:9.2013
Molecular neurodegeneration ; 8, Heft 1 (13.9.2013), 1, 9.2013
- Creator
-
Decourt, Boris
- Contributor
-
Walker, Aaron
Gonzales, Amanda
Malek-Ahmadi, Michael
Liesback, Carolyn
Davis, Kathryn
Belden, Christine
Jacobson, Sandra
Sabbagh, Marwan
SpringerLink (Online service)
- DOI
-
10.1186/1750-1326-8-S1-P14
- URN
-
urn:nbn:de:1111-2016073073362
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Decourt, Boris
- Walker, Aaron
- Gonzales, Amanda
- Malek-Ahmadi, Michael
- Liesback, Carolyn
- Davis, Kathryn
- Belden, Christine
- Jacobson, Sandra
- Sabbagh, Marwan
- SpringerLink (Online service)
Other Objects (12)
Role of BACE1 in Alzheimer’s synaptic function
Function and substrates of the Alzheimer´s disease protease BACE1
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
The Alzheimer's disease β-secretase enzyme, BACE1
BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease
CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease
Sorting out the cell biology of Alzheimer’s disease: focus on BACE1 and APP
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression
Role of BACE1 in Alzheimer’s synaptic function
Function and substrates of the Alzheimer´s disease protease BACE1
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
The Alzheimer's disease β-secretase enzyme, BACE1
BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease
CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease
Sorting out the cell biology of Alzheimer’s disease: focus on BACE1 and APP
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression
Role of BACE1 in Alzheimer’s synaptic function
Function and substrates of the Alzheimer´s disease protease BACE1
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
The Alzheimer's disease β-secretase enzyme, BACE1
BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease
CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease
Sorting out the cell biology of Alzheimer’s disease: focus on BACE1 and APP
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
BACE1, the Alzheimer's beta-secretase enzyme, in health and disease